 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Aldeyra Therapeutics Inc. (ALDX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-03-26 Sale | 2019-03-28 5:10 pm | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 96,743 | $10.01 | $968,397 | 8,763 (Indirect) | View |
| 2019-09-05 Purchase | 2019-09-09 4:37 pm | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commerical Officer | 4,329 | $4.68 | $20,260 | 6,148 (Direct) | View |
| 2019-09-05 Purchase | 2019-09-09 4:38 pm | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 3,200 | $4.71 | $15,072 | 35,774 (Direct) | View |
| 2019-09-06 Purchase | 2019-09-10 5:01 pm | Aldeyra Therapeutics Inc. | ALDX | Clark David J Chief Medical Officer | 5,000 | $5.0622 | $25,311 | 17,878 (Direct) | View |
| 2019-09-09 Purchase | 2019-09-11 4:05 pm | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 20,000 | $4.9982 | $99,963 | 60,000 (Direct) | View |
| 2019-09-09 Purchase | 2019-09-11 4:05 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 20,000 | $5.1412 | $102,824 | 578,991 (Direct) | View |
| 2019-09-11 Purchase | 2019-09-13 07:54 am | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 20,000 | $5.8902 | $117,805 | 80,000 (Direct) | View |
| 2019-09-12 Purchase | 2019-09-16 4:15 pm | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 1,700 | $5.8613 | $9,964 | 19,644 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 13,000 | $5.8454 | $75,990 | 591,991 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 07:36 am | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 5,000 | $6 | $30,000 | 85,000 (Direct) | View |
| 2019-09-13 Purchase(A) | 2019-09-17 4:21 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 21,547 | $5.9149 | $127,449 | 600,538 (Direct) | View |
| 2019-09-17 Purchase | 2019-09-19 4:23 pm | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,700 | $5.85 | $9,945 | 18,644 (Direct) | View |
| 2019-09-18 Purchase | 2019-09-20 07:37 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 14,288 | $5.9116 | $84,465 | 614,826 (Direct) | View |
| 2019-09-23 Purchase | 2019-09-25 07:40 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 8,680 | $5.8102 | $50,433 | 623,506 (Direct) | View |
| 2019-09-30 Purchase | 2019-10-02 07:36 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 8,710 | $5.6812 | $49,483 | 632,216 (Direct) | View |
| 2019-12-16 Purchase | 2019-12-18 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 20,000 | $5.0954 | $101,908 | 652,216 (Direct) | View |
| 2020-03-16 Purchase | 2020-03-17 4:38 pm | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 40,000 | $2.75 | $110,000 | 125,000 (Direct) | View |
| 2020-07-09 Purchase | 2020-07-13 4:30 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 3,200,000 | $4.25 | $13,600,000 | 6,285,458 (Indirect) | View |
| 2021-01-07 Purchase | 2021-01-11 9:53 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,050,000 | $8.7644 | $9,202,668 | 7,335,458 (Indirect) | View |
| 2021-01-19 Purchase | 2021-01-21 5:24 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,368,421 | $9.5 | $13,000,000 | 8,703,879 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-03-05 Option Award | 2019-03-07 5:30 pm | N/A 2029-03-04 | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commercial Officer | 45,212 | $8.05 | 45,212 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 4:38 pm | 2020-06-04 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 18,951 | $7.06 | 1,653 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 4:38 pm | 2020-06-04 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 1,763 | $7.06 | 1,653 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 4:38 pm | 2020-06-04 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 1,653 | $7.06 | 1,653 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:34 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 18,951 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:34 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 1,102 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:35 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 18,951 | $7.06 | 3,305 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:35 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 771 | $7.06 | 3,305 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:35 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 3,305 | $7.06 | 3,305 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 18,951 | $7.06 | 771 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 6,611 | $7.06 | 771 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 771 | $7.06 | 771 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 18,951 | $7.06 | 2,204 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 2,204 | $7.06 | 2,204 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:41 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 18,951 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:41 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,653 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:41 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,102 | $7.06 | 1,102 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 5:17 pm | N/A 2030-01-12 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 24,264 | $6.15 | 24,264 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:44 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 250,000 | $0 | 450,865 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:44 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 250,000 | $3.78 | 450,865 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:44 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 450,865 | $3.78 | 450,865 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:46 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commercial Officer | 250,000 | $0 | 247,480 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:46 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commercial Officer | 247,480 | $3.78 | 247,480 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:49 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 250,000 | $0 | 137,707 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:49 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 137,707 | $3.78 | 137,707 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-06 4:42 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commercial Officer | 247,480 | $0 | 250,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-06 4:42 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commercial Officer | 250,000 | $3.78 | 250,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-06 4:44 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 137,707 | $0 | 250,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-06 4:44 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 250,000 | $3.78 | 250,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:49 pm | 2021-06-09 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 26,503 | $5.02 | 2,311 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:49 pm | 2021-06-09 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 2,465 | $5.02 | 2,311 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:49 pm | 2021-06-09 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 2,311 | $5.02 | 2,311 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:45 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 26,503 | $5.02 | 3,082 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:45 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 3,082 | $5.02 | 3,082 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:46 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 26,503 | $5.02 | 1,541 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:46 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 1,541 | $5.02 | 1,541 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:47 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 26,503 | $5.02 | 4,623 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:47 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 1,079 | $5.02 | 4,623 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:47 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 4,623 | $5.02 | 4,623 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:48 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 26,503 | $5.02 | 1,079 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:48 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 9,245 | $5.02 | 1,079 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:48 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 1,079 | $5.02 | 1,079 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:48 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 26,503 | $5.02 | 26,503 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:51 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 26,503 | $5.02 | 1,541 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:51 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 2,311 | $5.02 | 1,541 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:51 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,541 | $5.02 | 1,541 (Direct) | View |